Cargando…
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products
Several soluble cytokines have been associated with microbicide-induced cervicovaginal inflammation, non-optimal vaginal microbiota, and risk of HIV acquisition. Many of these biomarkers are used in preclinical assays to estimate the safety of vaginally applied products. However, there are currently...
Autores principales: | Happel, Anna-Ursula, Sivro, Aida, Liebenberg, Lenine, Passmore, Jo Ann, Mitchell, Caroline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580790/ https://www.ncbi.nlm.nih.gov/pubmed/36303630 http://dx.doi.org/10.3389/frph.2022.899277 |
Ejemplares similares
-
The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract
por: Jewanraj, Janine, et al.
Publicado: (2020) -
Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017) -
Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized Trial
por: Balle, Christina, et al.
Publicado: (2022) -
Postmenopausal Vaginal Microbiome and Microbiota
por: de Oliveira, Nayara Santos, et al.
Publicado: (2022) -
Characterization of the Ovine Vaginal Microbiome and Inflammation Patterns as an Improved Testing Model of Human Vaginal Irritation
por: Pyles, Richard B., et al.
Publicado: (2021)